Search research articles
Contact Us
Filters
Showing results (141-150 of 272) with videos related to
Page
of 28
Sort By:
Der Urologe. Ausg. A
|
August 2, 2021
[On the practice of therapy decision in locally limited prostate cancer: surgery vs. radiation-who benefits? : Allocation and results of a monocentric, cumulative long-term study]
W -D U Böhm, R Koch, S Latarius, et al.
BJU International
|
October 13, 2004
Induction of proliferation and differentiation of cultured urothelial cells on acellular biomaterials
Gouya Ram-Liebig, Axel Meye, Oliver W Hakenberg, et al.
European Urology
|
January 22, 2005
Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy
Michael Froehner, Rainer Koch, Rainer J Litz, et al.
Cancer Letters
|
April 15, 2003
Tissue specific expression and serum levels of human tissue factor in patients with urological cancer
Yvonne Förster, Axel Meye, Sybille Albrecht, et al.
Urologia Internationalis
|
March 20, 2014
Primary tumor size in renal cell cancer in relation to the occurrence of synchronous metastatic disease
Stefan Zastrow, Anh Phuong, Immanuel von Bar, et al.
BJU International
|
December 2, 2011
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
Peter Iversen, David G McLeod, William A See, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 30, 2008
Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man
Melinda Wuest, Birgit Eichhorn, Marc O Grimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells
Kai Kraemer, Susanne Fuessel, Uta Schmidt, et al.
The Journal of Urology
|
November 16, 2004
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years
Manfred P Wirth, William A See, David G McLeod, et al.
The Journal of Urology
|
March 22, 2008
Interaction between age and comorbidity as predictors of mortality after radical prostatectomy
Michael Froehner, Rainer Koch, Rainer J Litz, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 272) with videos related to
Sort By:
Page
of 28
Der Urologe. Ausg. A
|
August 2, 2021
[On the practice of therapy decision in locally limited prostate cancer: surgery vs. radiation-who benefits? : Allocation and results of a monocentric, cumulative long-term study]
W -D U Böhm, R Koch, S Latarius, et al.
BJU International
|
October 13, 2004
Induction of proliferation and differentiation of cultured urothelial cells on acellular biomaterials
Gouya Ram-Liebig, Axel Meye, Oliver W Hakenberg, et al.
European Urology
|
January 22, 2005
Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy
Michael Froehner, Rainer Koch, Rainer J Litz, et al.
Cancer Letters
|
April 15, 2003
Tissue specific expression and serum levels of human tissue factor in patients with urological cancer
Yvonne Förster, Axel Meye, Sybille Albrecht, et al.
Urologia Internationalis
|
March 20, 2014
Primary tumor size in renal cell cancer in relation to the occurrence of synchronous metastatic disease
Stefan Zastrow, Anh Phuong, Immanuel von Bar, et al.
BJU International
|
December 2, 2011
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
Peter Iversen, David G McLeod, William A See, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 30, 2008
Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man
Melinda Wuest, Birgit Eichhorn, Marc O Grimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells
Kai Kraemer, Susanne Fuessel, Uta Schmidt, et al.
The Journal of Urology
|
November 16, 2004
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years
Manfred P Wirth, William A See, David G McLeod, et al.
The Journal of Urology
|
March 22, 2008
Interaction between age and comorbidity as predictors of mortality after radical prostatectomy
Michael Froehner, Rainer Koch, Rainer J Litz, et al.
Page
of 28